Skip to main content

Table 1 Comparison of clinical and demographic data between patients with a MBL level above or below the median

From: High levels of mannose-binding lectin are associated with lower pulse wave velocity in uraemic patients

  MBL < 722 ug/L MBL >722 ug/L
  N = 49 N = 49
Age (years) 45.3 ± 13.0 41.6 ± 12.4
ESRD (months) 29 (0–168) 33 (0–120)
Dialysis status:   
Haemodialysis (N) 34 32
Peritoneal dialysis (N) 13 13
Pre-dialysis (N) 2 4
Haemodialysis, venous access: Arterio-venous fistulae/permanently haemodialysis catheter (N) 15/19 15/17
Tx status (living donor/deceased donor) 22/27 26/23
Myocardial infarction (N) 2 2
Smoking (N) 15 14
Stroke (N) 3 2
Diabetes (N) 3 5
Impaired fasting glucose (N) 1 2
Impaired glucose tolerance (N) 21 13
Normal glucose tolerance (N) 24 29
Fasting plasma glucose (mmol/L) 5.0 ± 0.4 5.1 ± 0.5
OGTT 120min(mmol/L) 8.0 ± 2.1 7.7 ± 2.1
ISI (index) 7.4 ± 4.1 7.9 ± 4.9
BMI (kg/m2) 24.2 ± 3.8 24.5 ± 3.6
PWV (m/s) 8.2 (5.6-15.8) 6.8 (5.2-16.4)*
AIX (%) 27 (-10;56) 20 (-7;50)
FMD (%) 3.8 (-8.3;19.2) 3.5 (-6.8;19.1)
NID (%) 10.5 (2.9;27.1) 11.5 (2.0;27.2)
Systolic blood pressure (mmHg) 143 ± 25 140 ± 19
Diastolic blood pressure (mmHg) 85 ± 12 84 ± 13
Number of antihypertensive drugs 2 (0–5) 3 (0–6)*
P-C-reactive protein (mg/L) 2 (1–40) 2 (1–21)
P-Homocystein (umol/L) 21 (11–62) 22 (12–150)
P-PTH (pmol/L) 21 (2–100) 20 (4–156)
P-ionized calcium (mmol/L) 1.19 ± 0.09 1.21 ± 0.09
P-phosphate (mmol/L) 1.8 ± 0.4 2.0 ± 0.6
  1. Data are presented as mean (SD) or median and range.
  2. MBL: Mannose Binding Lectin, ESRD: end-stage renal disease,
  3. Tx: transplantation, BMI: body mass index, PTH: parathyroidea hormone,
  4. OGTT: oral glucose tolerance index, ISI: insulin sensitivity index.
  5. PWV: pulse wave velocity,
  6. AIX: Augmentation Index, FMD: flow mediated vasodilatation,
  7. NID: nitroglycerin independent dilatation,
  8. *P < 0.05.